Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000899243-21-035470

Options or other derivatives

  • Chief Legal Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ZDRAVESKI ZORAN Chief Legal Officer 2021-09-07 Grant or award · Stock Option (right to buy) +150,000 150,000 D
Loading xslF345X03/doc4.xml…